Primary prevention of stroke goes along two lines. By mass strategy society
promotes healthier life styles and by high risk strategy individuals with
certain risk factors are indentified and specific prophylactic measures ins
tituted. Treatment of arterial hypertension reduces stroke risk. Antihypert
ensive treatment by diuretics is more cost effective than other antihyperte
nsive drugs, and more so in the elderly than in the middle aged. In patient
s with non-vascular atrial fibrillation (NVAF) and a high risk of ischaemic
stroke anticoagulation is cast saving provided the frequency of intracereb
ral haemorrhage is low. In low risk NVAF patients aspirin is to be preferre
d, both clinically and economically. In secondary stroke prevention in pati
ents without a cardioembolic source aspirin as well as the combination of a
spirin and dipyridamole are cost saving. Eur J Neurol 6 (suppl 2):S25-S29 (
C) 1999 Lippincott Williams & Wilkins.